Mark S. Ordan - 01 Jun 2026 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: MD
Reported as of: 01 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2026, 17:00:13 UTC
Prior SEC filing: 01 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Mary Ann E. Moore, Attorney-in-Fact

Key filing fact

Mark S. Ordan filed Form 4 for Pediatrix Medical Group, Inc. (MD) on 03 Jun 2026.

Key facts

This page summarizes Mark S. Ordan's Form 4 filing for Pediatrix Medical Group, Inc. (MD).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2026, 17:00.

Change

Previous filing in this sequence was filed on 01 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001208541 Primary reporting owner

ORDAN MARK S

Relationship: Chief Executive Officer, Director
Address: 1301 CONCORD TERRACE, SUNRISE
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Signature date: 03 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MD transaction

Common Stock

Award

Transaction value
Shares: +127,198
Change %: +42%
Price: $0.000000^*
Shares after: 430,003
Date: 01 Jun 2026
Ownership: Direct
Footnotes: F1

MD transaction

Common Stock

Tax liability

Transaction value
Shares: -19,119
Change %: -4.4%
Price: $21.54^*
Shares after: 410,884
Date: 01 Jun 2026
Ownership: Direct
Footnotes: F2

MD transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -97,174
Change %: -24%
Price: $0.000000^*
Shares after: 313,710
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F3

MD transaction

Common Stock

Award

Transaction value
Shares: +97,174
Change %: +31%
Price: $0.000000^*
Shares after: 410,884
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.

Footnote F2

Represents 19,119 restricted shares withheld for payment of taxes upon vesting of shares.

Footnote F3

The Reporting Person filed a Form 4 on June 3, 2025, reporting an annual equity award of 194,347 restricted shares granted on June 1, 2025 pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (as further amended and restated on May 7, 2026, the "Plan"), which award, as originally reported, vested as to twenty-five percent (25%) on June 1, 2026, with the remaining portion scheduled to vest twenty-five percent (25%) on June 1, 2027 and fifty percent (50%) on June 1, 2028, in each case subject to the terms of the Plan. Due to the annual award limitations of the Plan, the award was revised so that the remaining fifty percent (50%) of the award that was scheduled to vest on June 1, 2028 was re-granted on June 2, 2026, which portion will still vest on June 1, 2028 in accordance with the original terms of the award, subject to the terms of the Plan and the underlying award agreement.